Drug Topics

AUGUST 5, 2025

The comparative effectiveness study included 48165 patients with T2D and moderate cardiovascular risk who were treated at 1 of 10 health systems in the United States between January 2013 and January 2023.

Specialty Pharmacies

Pharmacy Times

AUGUST 11, 2025

February 2013. BMC Health Serv Res. 2024;24(1):576. doi:10.1186/s12913-024-11047-3 5. American Society of Health-System Pharmacists and American Pharmacists Association. ASHP-APhA Medication Management in Care Transitions Best Practices. Accessed July 7, 2025. Tasseff N, Axtell S, Nixon B.

Hospitals

Pharmaceutical Commerce

JUNE 18, 2025

Stakeholders are aware that this federal law—enforced by the FDA and originally enacted in 2013 as a way to help bolster security and traceability of products passing through the pharma supply chain—has seen its share of delays and exemptions over the years. The most recent enforcement delay came Oct.

Specialty Pharmacies

Hospital Pharmacy Europe

JULY 9, 2025

million valsartan users from 2013-17 found no increase in overall cancer risk but observed slightly higher incidences of liver cancer (hazard ratio (HR) 1.12) and melanoma (HR 1.10) among those exposed to NDMA-contaminated valsartan. Despite widespread concern, the actual clinical risk from nitrosamine-contaminated drugs remains unclear.

Compounding

Blog: Ask a Student Pharmacist

JULY 28, 2025

. + Lead and Supporting Preceptor Bios Primary Preceptor: Brady Ritscher, PharmD Lead Pharmacist- Outpatient Pharmacy Brady graduated from Saint Mary’s University of Minnesota in 2013 with a degree in biochemistry and then from Concordia University of Wisconsin School of Pharmacy in 2017. Brady has worked at St.

Hospitals

Pharmaceutical Technology

AUGUST 5, 2025

The vaccine was approved in Europe in 2013, with the UK becoming the first country to offer the vaccine as part of its routine childhood immunisation schedule in 2015. GlobalData Strategic Intelligence US Tariffs are shifting - will you react or anticipate?

Vaccines

Pharmacy Times

JULY 10, 2025

Factors associated with relapse in schizophrenia despite adherence to long-acting injectable antipsychotic therapy. International Clinical Psychopharmacology, 31 (4), 202–209. Lafeuille, M. Lefebvre, P., Fastenau, J., Doshi, D., & & Duh, M. Journal of Medical Economics, 16 (11), 1290–1299.

FDA

PharmTech

JUNE 23, 2025

This labeling would likely have been approved for a salt-active moiety after USP ’s salt policy was implemented in 2013. This label demonstrates labeling for a pre-2013 approved salt drug product—the entire salt drug weight (Olddrug palmitate) is dosed as the active moiety. Salt drug dosage form label. YouTube.com , Dec. Teixeira, M.

Compounding

Pharmacy Times

JUNE 20, 2025

Touchstone Books; 2013. Time Enough for Love. Putnam’s Sons; 1973. Hyperbole and a Half: Unfortunate Situations, Flawed Coping Mechanisms, Mayhem, and Other Things That Happened. Rao KV, Gulbis AM, Mahmoudjafari Z. 2022;5(11):1112-1120. doi:10.1002/jac5.1693 4. 6 challenges facing community oncology practices.

Compounding

Pharmacy Times

JULY 9, 2025

A total of 277 patients (median age: 66 years; range: 30–89 years) with NSCLC who initiated treatment between October 2013 and August 2023 were enrolled. 1 The median time of follow-up was about 10.4 months for patients from RPCCC (range: 0.7–52.0 months) and 6.4 months for those from USC (range: 0.7–88.3 months).

Immunization

Pharmacy Times

JULY 24, 2025

1 In 2013, Humira was approved in China as a treatment for ankylosing spondylitis, a chronic inflammatory disease that causes axial arthritis and often results in inflammatory lower back pain early in the disease’s course.

Compounding Pharmacies

Pharmacy Times

JULY 28, 2025

Cambridge University Press; 2013:129-236. Psychiatry Clin Neurosci. 2015;69(6):321-334. doi:10.1111/pcn.12270 12270 Stahl SM. Antipsychotic agents. In: Stahl’s Essential Psychopharmacology: Neuroscientific Basis and Practical Applications. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders.

Compounding Pharmacies

The Checkup by Singlecare

NOVEMBER 4, 2024

Trintellix (vortioxetine) is a brand-name prescription medication that was approved by the Food and Drug Administration (FDA) in 2013 to treat major depressive disorder (MDD) in adults. It belongs to a class of drugs known as serotonin modulators and stimulators (SMS) that balance serotonin, a substance in the brain that affects mood.

Insurance

The Checkup by Singlecare

JUNE 24, 2025

Starting in 2013, overdose deaths involving synthetic opioids such as fentanyl and illegally manufactured fentanyl (IMF) started increasing. The first wave of opioid overdose deaths started in the 1990s due to the rise in prescriptions of commonly prescribed opioids such as codeine, oxycodone, and methadone.

FDA

PharmaVoice

JULY 8, 2025

The FDA approved the first MEK inhibitor, a melanoma drug from Novartis, in 2013. The broad mechanism allows them to target multiple tumor types, including those with RAS mutations, which are common in melanoma, pancreatic, colorectal and lung cancers.

Immunization

The Checkup by Singlecare

DECEMBER 27, 2024

A 2013 review of studies looked at many common factors that often affect the absorption of drugs like Xarelto and found that sex, body weight, and ethnicity did not significantly affect how quickly the drug is cleared from the body; only advanced age and kidney and/or liver disease were shown to impact its half-life.

Dosage

The Checkup by Singlecare

MAY 6, 2025

CDC, 2024) Fentanyl overdose statistics Overdose deaths from drugs like fentanyl rose sharply after 2013, reaching 22.2 (SAMHSA, 2024) In 2022, only 1 in 4 U.S. adults who needed treatment for opioid use disorder (OUD) received medication for it. deaths per 100,000 people in 2023.

Labelling

PharmD Live

JUNE 16, 2025

Let 2025 be the year your organization redefines care through medication adherence. Ready to activate change? Partner with PharmD Live today. References: National Community Pharmacists Association. Medication adherence in America: A national report card. link] Neiman, A. B., Ruppar, T.,  G., & Thorpe, P. G. 2017, November 17).

Hospitals

The Thyroid Pharmacist

MAY 9, 2025

In a 2013 randomized controlled trial of women with hot flashes, those who took a progesterone medication saw an increase in thyroid hormone levels. She and I met in 2013 after I reached out and told her how much I loved her work. Thus, excess estrogen levels and low progesterone levels can cause hypothyroidism.

Immunization

The Checkup by Singlecare

JUNE 18, 2025

In 2013, the Food & Drug Administration approved Trintellix for use in treating symptoms of MDD, a severe and often chronic form of depression. Here’s what to know about the side effects of starting Trintellix, including how to manage them, when they might improve, and when to contact your healthcare provider. What is Trintellix used for?

Dosage

Pharmacy Times

JULY 1, 2025

Using data from the National Cancer Database, they performed a retrospective analysis on patients diagnosed with metastatic HR–/HER2+ breast cancer between January 2013 and December 2020. in 2013 to 80.9% The patients were assigned to 1 of 2 groups: those who received HER2-targeting therapies and those who did not.

Compounding Pharmacies

PharmTech

JUNE 24, 2025

Belgium-based eTheRNA was founded in 2013 and developed mRNA and LNP technologies. In February 2023, CureVac closed a US$250 million public offering and has a strong cash position to continue the development of its promising pipeline (14, 16).

Vaccines

The Checkup by Singlecare

JUNE 25, 2025

between 2013 and 2014. (WHO, 2025) For both men and women, obesity is most common among adults ages 40–59. ( CDC , 2024) The percentage of people with severe obesity, defined as a BMI of 40 or higher, is slowly growing: It was 9.7% between 2021 and 2023, up from 7.7% CDC, 2024) How many people use Mounjaro for Type 2 diabetes?

Insurance

Pharmaceutical Commerce

JUNE 16, 2025

October 24, 2013. About the Author Sean O’Hearen is Founder and Principal Consultant at 1st Line Partners. References 1. Southwick, N. Counterfeit Drugs Kill 1 Mn People Annually: Interpol. Insight Crime. 2024 Symposium on Public Health Strategies to Combat Substandard and Falsified Drugs. Johns Hopkins Bloomberg School of Public Health.

Communication

STAT

MARCH 28, 2025

Joung, an early pioneer of the gene-editing technology, was the first to show CRISPR could target and cut DNA inside an embryo — in zebrafish — back in 2013. If, of course, society decided that was a good idea.

Pharmaceutical Technology

JUNE 25, 2025

Vizamyl was first approved in 2013 to estimate beta amyloid neuritic plaque density in adult patients with cognitive impairment. “Now quantification can also play a critical role in initiating and monitoring amyloid-targeted therapy for Alzheimer’s disease and determining when it can be discontinued.”

Labelling

The FDA Law Blog

JULY 10, 2025

The announcement goes on to say that, due to the historical practice of “refrain[ing] from publishing CRLs for pending applications, sponsors often misrepresent the rationale behind FDA’s decision to their stakeholders and the public” (emphasis added).

FDA

The Thyroid Pharmacist

MAY 15, 2025

doi:10.1155/2013/872632 [6] Sadahira T, Wada K, Araki M, et al. Clin Rev Allergy Immunol. 2012;42(1):71-78. doi:10.1007/s12016-011-8291-x [5] Rashid T, Wilson C, Ebringer A. The link between ankylosing spondylitis, Crohns disease, Klebsiella, and starch consumption. Clin Dev Immunol. 2013;2013:872632. Int J Urol. 2021;28(10):1026-1031.

Immunization

The Checkup by Singlecare

JUNE 6, 2025

Trintellix (vortioxetine) is a relatively new antidepressant medication that was approved by the Food & Drug Administration (FDA) in 2013 for the treatment of major depressive disorder (MDD), a severe and persistent type of depression , in adults. That said, it’s not impossible to gain weight while taking Trintellix.

Dosage

The Thyroid Pharmacist

AUGUST 1, 2025

2013; 9(6): 201-206; Moore ER, Anderson GC, Bergman N, Dowswell T. Originally published January 2013, updated July 2016 and republished with the express permission of the author. 2013 Jul-Aug;58(4):457-61. Epub 2013 Jul 19. 2013 Feb;27(1):5-12. Published 2013 May 30. 2022 Apr 28;14(9):1846. J Hum Lact.

Health and Personal Care Stores

European Pharmaceutical Review

DECEMBER 30, 2024

He joined as founding Chief Operating Officer in 2013, later becoming Chief Manufacturing Officer, where he led the design, build and GMP licensing of the 75m CGT Catapult facility in Stevenage, as well as its Braintree site. In 2024, he became Chief Technology Officer, focusing on digital, automation and technology strategies.

Medical Schools

Drug Topics

JUNE 20, 2025

The search included articles between January 2013 and June 2024. They conducted a literature review of PubMed, clinicaltrials.gov, and Embase databases to identify studies that explored vaccines for dermatological diseases. 1 Throughout the past 10 years, development of vaccines for preventing skin diseases has made significant progress.

Vaccines

Drug Topics

AUGUST 6, 2025

But aside from the moral standings behind the politicization of abortion in the US, the pressures toward access have correlated with an overall decrease in abortions since 2013. 3 Researchers conducted an online, cross-sectional survey for clinicians that commonly serve adolescent patients.

Specialty Pharmacies

The FDA Law Blog

JULY 7, 2025

It’s not clear why there was a delay but better late than never.

FDA

STAT

MARCH 12, 2025

The  Critical Medicines Act has been proposed at a time when the EC has become increasingly concerned about shortages, which have been rising since 2013 and peaked during the COVID-19 pandemic, as well as variable access to drugs between EU member states leading to accusations that some are stockpiling to the detriment of others.

Compounding

European Pharmaceutical Review

APRIL 8, 2025

Sustainability. 2020; 12(3), 981. Lezotre PL. International Cooperation, Convergence And Harmonization Of Pharmaceutical Regulations: A Global Perspective. Academic Press. The post Beyond instruments: streamlining process technology implementation in biopharmaceutical manufacturing appeared first on European Pharmaceutical Review.

Documentation

European Pharmaceutical Review

DECEMBER 23, 2024

EMA/CHMP/ICH/353369/2013. EMA/CHMP/ICH/83812/2013. ICH Q3D(R2) Elemental Impurities – Scientific Guideline. 2 May 2022. ICH Q3E Guideline for Extractables and Leachables (E&L). Final Concept Paper. 30 June 2020. 18 July 2023. Safety Based Limits for the Control of Impurities in Drug Substances and Drug Products: A Review.

Vaccines